» Articles » PMID: 30085162

Pathogenicity of Ebola and Marburg Viruses Is Associated With Differential Activation of the Myeloid Compartment in Humanized Triple Knockout-Bone Marrow, Liver, and Thymus Mice

Overview
Journal J Infect Dis
Date 2018 Aug 8
PMID 30085162
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Ebola virus (EBOV) and Marburg virus (MARV) outbreaks are highly lethal, and infection results in a hemorrhagic fever with complex etiology. These zoonotic viruses dysregulate the immune system to cause disease, in part by replicating within myeloid cells that would normally innately control viral infection and shape the adaptive immune response. We used triple knockout (TKO)-bone marrow, liver, thymus (BLT) humanized mice to recapitulate the early in vivo human immune response to filovirus infection. Disease severity in TKO-BLT mice was dissimilar between EBOV and MARV with greater severity observed during EBOV infection. Disease severity was related to increased Kupffer cell infection in the liver, higher levels of myeloid dysfunction, and skewing of macrophage subtypes in EBOV compared with MARV-infected mice. Overall, the TKO-BLT model provided a practical in vivo platform to study the human immune response to filovirus infection and generated a better understanding of how these viruses modulate specific components of the immune system.

Citing Articles

Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control.

Wang S, Li W, Wang Z, Yang W, Li E, Xia X Signal Transduct Target Ther. 2024; 9(1):223.

PMID: 39256346 PMC: 11412324. DOI: 10.1038/s41392-024-01917-x.


Filoviruses: Scientific Gaps and Prototype Pathogen Recommendation.

Dupuy L, Spiropoulou C, Towner J, Spengler J, Sullivan N, Montgomery J J Infect Dis. 2023; 228(Suppl 6):S446-S459.

PMID: 37849404 PMC: 11009505. DOI: 10.1093/infdis/jiad362.


Of mice and Mike-An underappreciated Ebola virus disease model may have paved the road for future filovirology.

Kuhn J, Schmaljohn C Antiviral Res. 2023; 210:105522.

PMID: 36592667 PMC: 9852096. DOI: 10.1016/j.antiviral.2022.105522.


Macrophage infection, activation, and histopathological findings in ebolavirus infection.

Wanninger T, Millian D, Saldarriaga O, Maruyama J, Saito T, Reyna R Front Cell Infect Microbiol. 2022; 12:1023557.

PMID: 36310868 PMC: 9597316. DOI: 10.3389/fcimb.2022.1023557.


SARS-CoV-2 Variant-Specific Infectivity and Immune Profiles Are Detectable in a Humanized Lung Mouse Model.

Di Y, Lew J, Goncin U, Radomska A, Rout S, Gray B Viruses. 2022; 14(10).

PMID: 36298826 PMC: 9612296. DOI: 10.3390/v14102272.


References
1.
Spengler J, Lavender K, Martellaro C, Carmody A, Kurth A, Keck J . Ebola Virus Replication and Disease Without Immunopathology in Mice Expressing Transgenes to Support Human Myeloid and Lymphoid Cell Engraftment. J Infect Dis. 2016; 214(suppl 3):S308-S318. PMC: 5050473. DOI: 10.1093/infdis/jiw248. View

2.
Mahanty S, Hutchinson K, Agarwal S, McRae M, Rollin P, Pulendran B . Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J Immunol. 2003; 170(6):2797-801. DOI: 10.4049/jimmunol.170.6.2797. View

3.
Bird B, Spengler J, Chakrabarti A, Khristova M, Sealy T, Coleman-McCray J . Humanized Mouse Model of Ebola Virus Disease Mimics the Immune Responses in Human Disease. J Infect Dis. 2015; 213(5):703-11. PMC: 4747627. DOI: 10.1093/infdis/jiv538. View

4.
Lavender K, Pace C, Sutter K, Messer R, Pouncey D, Cummins N . An advanced BLT-humanized mouse model for extended HIV-1 cure studies. AIDS. 2017; 32(1):1-10. PMC: 5718929. DOI: 10.1097/QAD.0000000000001674. View

5.
Fernando L, Qiu X, Melito P, Williams K, Feldmann F, Feldmann H . Immune Response to Marburg Virus Angola Infection in Nonhuman Primates. J Infect Dis. 2015; 212 Suppl 2:S234-41. DOI: 10.1093/infdis/jiv095. View